Kanpur: India is witnessing an alarming rise in Type 1 & Type 2 diabetes cases, with nearly 10% of adults between 18 and 85 years suffering from the disease. That’s approximately 100 million people battling diabetes, while an additional 135 million are in the prediabetes stage. With such staggering numbers, any news of a potential cure generates widespread excitement. Recently, reports surfaced of a Type 1 diabetes patient being “cured” through a breakthrough treatment. This brought hope to the 2.5 million Indians living with Type 1 diabetes.
However, the story behind the treatment is far more complex than it seems. The so-called cure involved the transplantation of beta cells derived from induced pluripotent stem cells (iPSCs), an incredibly expensive procedure. Additionally, due to the autoimmune nature of diabetes, there are concerns that the body’s immune system may eventually destroy these transplanted cells, raising questions about the long-term effectiveness of this approach.
A New Hope for Type 2 Diabetes: Fat-Derived Cellular Concentrate
While the potential cure for Type 1 diabetes may still be in its experimental stages, a promising development in the treatment of Type 2 diabetes is making headlines. A groundbreaking trial conducted at GSVM Medical College in Kanpur has shown that a cellular concentrate derived from fat tissue is highly effective in managing uncontrolled Type 2 diabetes. This minimally invasive procedure has shown remarkable results, with patients’ HbA1C levels dropping from 10 to 6.5 in just six months—without requiring any changes to lifestyle, diet, or medication.
What is Fat-Derived Cellular Concentrate Transplant?
This treatment involves the use of a cellular concentrate extracted from the patient’s fat tissue, which is processed using a patented Australian technique. The procedure requires a coordinated effort between plastic surgeons, cellular transplant surgeons, and lab experts. The concentrate is then transplanted into the patient, where it helps in managing:
- Uncontrolled Type 2 Diabetes
- Diabetic complications, such as nerve and kidney damage
- Cardiac complications related to diabetes
Proven Success of Type 2 Diabetes at GSVM Medical College
The trial at GSVM Medical College has opened new avenues for diabetes management. Prof. Dr. B.S. Rajput, a visiting professor at GSVM and a consultant cellular transplant surgeon, spearheaded this initiative. After the initial success of the trial, Dr. Rajput treated several other patients with Type 2 diabetes, many of whom had severe renal and cardiac complications. The outcomes have been overwhelmingly positive, offering a glimmer of hope for millions living with the disease.
A Promising Future in Type 2 Diabetes Treatment
Dr. Rajput’s pioneering work with fat-derived cellular concentrate transplants has the potential to revolutionize diabetes care, particularly for Type 2 diabetes patients. While this procedure may not yet be a cure, its effectiveness in controlling the disease and reducing complications is undeniable. As research continues, the possibility of a broader application for this innovative treatment grows stronger, offering new hope for the millions affected by diabetes worldwide.
Dr. B.S. Rajput
Visiting Professor, GSVM Medical College, Kanpur
Consultant Cellular Transplant Surgeon, ACI Cumballa Hill Hospital, Mumbai & Criticare Asia Hospital, Juhu, Mumbai
Website: https://www.drrajput.com/
Email: [email protected]
This breakthrough marks a significant step forward in the fight against diabetes, raising the question: Could a cure for diabetes be closer than we think?